The major overall goals of this Program Project Grant, """"""""Dendritic Cell Biology and Therapy"""""""" is to coordinately explore the major unsolved issue of modern cellular immunology, i.e. the difference in parameters allowing induction of tolerance or immunity to defined antigens. It is the central precept of this grant that progress in application of dendritic cells to the treatment of important human disease will best be realized by a coordinated approach engaging scientists studying cancer, transplantation and autoimmunity. It has long been appreciated that dendritic cells are specialized presenting cells (APC) with a unique ability to prime effective immune responses, and that this may give them a special importance in several human disease states known to have an immunological basis. All along, while great strides were being made in the understanding of the role of specific T cells and antibodies in mediating allergy, autoimmunity, graft rejection, or tumor immunity, it was also clear that these effectors represented the end stage of an immune response, the outcome of which was likely determined at its very initiation by the type of APC and the cytokine conditions under which the antigen was first presented. As is usually the case in science, testing of ideas must await development of new techniques and reagents, which are now available to study DC's. We envision 5 Projects and 4 Cores in the revised applications as listed below: I. Mechanism of Dendritic Cell-Based Tumor Immunization. Louis A. Falo and Michael T. Lotze. II. Dendritic Cell Mediated Therapy of Auto Immune Diabetes. Penelope Morel, Angus W. Thomson, Hideaki Tahara. III. Dendritic Cell Modulation of Autoreactive T- Lymphocytes. Timothy Wright, Susan McCarthy IV. Dendritic Cell Therapies Elicit Effective Anti-tumor Responses. Michael T. Lotze, Joseph Baar, Walter Storkus, Louis Falo, Andrew Amoscato. A. Administrative ore. Michael T. Lotze and Olivera J. Finn. B. Immunologic Monitoring and Diagnostic Laboratories . Theresa Whiteside, Elaine Elder. C. Imaging Core, Simon Watkins, Ronald Jaffe. D. Vector Core, Paul Robbins, Leaf Huang, Hideaki Tahara.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA073743-01A1S1
Application #
2907501
Study Section
Subcommittee G - Education (NCI)
Program Officer
Hecht, Toby T
Project Start
1998-01-26
Project End
2002-12-31
Budget Start
1998-01-26
Budget End
1998-12-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Macatangay, Bernard J C; Riddler, Sharon A; Wheeler, Nicole D et al. (2016) Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells. J Infect Dis 213:1400-9
Lohmueller, Jason J; Sato, Shuji; Popova, Lana et al. (2016) Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential. Sci Rep 6:31740
Zhang, Lixin; Vlad, Anda; Milcarek, Christine et al. (2013) Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms. Cancer Immunol Immunother 62:423-35
Sun, Chengqun; Heid, Michelle E; Keyel, Peter A et al. (2013) The second transmembrane domain of P2X7 contributes to dilated pore formation. PLoS One 8:e61886
Kimura, Takashi; McKolanis, John R; Dzubinski, Lynda A et al. (2013) MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res (Phila) 6:18-26
Miskov-Zivanov, Natasa; Turner, Michael S; Kane, Lawrence P et al. (2013) The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Sci Signal 6:ra97
Keyel, Peter A; Roth, Robyn; Yokoyama, Wayne M et al. (2013) Reduction of streptolysin O (SLO) pore-forming activity enhances inflammasome activation. Toxins (Basel) 5:1105-18
Keyel, Peter A; Tkacheva, Olga A; Larregina, Adriana T et al. (2012) Coordinate stimulation of macrophages by microparticles and TLR ligands induces foam cell formation. J Immunol 189:4621-9
Cramer, Daniel W; Finn, Olivera J (2011) Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol 23:265-71
Morel, Penelope A; Turner, Michael S (2011) Dendritic cells and the maintenance of self-tolerance. Immunol Res 50:124-9

Showing the most recent 10 out of 90 publications